Home> Blog> China Top 10 Rabies Vaccine For Human Potential Enterprises

China Top 10 Rabies Vaccine For Human Potential Enterprises

May 13, 2024
Rabies is a deadly virus that can be transmitted to humans through the bite of an infected animal. The rabies vaccine for humans is a crucial preventive measure to protect against this fatal disease. It is recommended for individuals at high risk of exposure, such as veterinarians and animal control workers. Getting vaccinated can save lives and prevent the spread of rabies.

Liaoning Chengda Biotechnology Co., Ltd.

Establishment time : 2000

website : www.lncd.com

Main Product : Probiotics, enzymes, feed additives

Company Profile

Liaoning Chengda Biotechnology Co., Ltd. is a leading biotechnology company specializing in the development and production of probiotics, enzymes, and feed additives. Founded in 2000, the company has grown to become a key player in the industry, serving markets in China, Southeast Asia, and the Middle East. With a focus on quality and innovation, Chengda Biotechnology continues to strive for excellence in providing solutions for animal nutrition and health.

Changchun Institute of Biological Products Co., Ltd.

Establishment time : 1941

website : http://www.cibp.cncq.com/

Main Product : Vaccines, biological products

Company Profile

Changchun Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company with a long history of producing high-quality vaccines and biological products. Founded in 1941, the company has grown to become a major player in the industry, serving both domestic and international markets. With a strong focus on research and development, CIBP continues to innovate and expand its product offerings to meet the growing demand for vaccines worldwide.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Chengdu Institute of Biological Products Co., Ltd.

Establishment time : 1967

website : www.cdibp.com.cn

Main Product : Vaccines, blood products, diagnostic reagents

Company Profile

Chengdu Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the production of vaccines, blood products, and diagnostic reagents. Established in 1967, the company has a strong presence in both domestic and international markets, with a large workforce of over 1,000 employees. With a focus on research and development, the company continues to innovate and expand its product offerings in the biopharmaceutical industry.

Wuhan Institute of Biological Products Co., Ltd.

Establishment time : Wuhan Institute of Biological Products Co., Ltd. was founded in 1965.

website :

Main Product : With over 50 years of experience, the company has established itself as a leading player in the industry.

Company Profile

For more information about the company and its products, visit their official website at http://www.whbp.com.cn/.

Shenzhen Kangtai Biological Products Co., Ltd.

Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.

website :

Main Product : With over 1000 employees, Kangtai is one of the leading biopharmaceutical companies in China.

Company Profile

To learn more about Shenzhen Kangtai Biological Products Co., Ltd., visit their website at www.kangtaibio.com.
Contact Us

Author:

Mr. Simba Li

Phone/WhatsApp:

+86 18946525326

Popular Products
You may also like
Related Information
Top 10 Most Popular Chinese Rabies Vaccine For Human Brands

Rabies vaccine for humans is a crucial preventive measure against the deadly rabies virus, typically transmitted through the bite of an infected animal. The vaccine is administered in a series of...

Asia's Top 10 Freeze Rabies Vaccine For Humans Brand List

Introducing the groundbreaking Freeze Rabies Vaccine for Humans! This innovative solution offers long-lasting protection against rabies, ensuring the safety of you and your loved ones. Say goodbye to...

List of Top 10 Rabies Vaccine For Human Brands Popular in European and American Countries

Protect yourself and your loved ones with our rabies vaccine for humans. Stay safe from this deadly virus with our reliable and effective vaccine. Don't wait until it's too late, get vaccinated today...

Top 10 China Rabies Vaccine For Humans Manufacturers

The rabies vaccine for humans is a crucial preventive measure against the deadly rabies virus transmitted through animal bites. With increasing awareness about the importance of vaccination, the...

Related Categories

Email to this supplier

Subject:
Email:
Message:

Your message must be betwwen 20-8000 characters

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send